Entelos Signs Anemia Research Deal With GlaxoSmithKline
February 04 2009 - 1:54AM
Dow Jones News
Entelos Inc. (ENTL.LN), which makes software that lets
pharmaceutical companies run "virtual" drug trials using computers,
said Wednesday it signed a research deal with GlaxoSmithKline PLC
(GSK.LN).
GlaxoSmithKline wants to use Entelos' Hematopoeisis PhysioLab
platform to develop drugs for anemia.
Financial terms weren't disclosed.
Company Web site: www.entelos.com
-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272;
jason.douglas@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Entelos Regs (London Stock Exchange): 0 recent articles
More Entelos Regs News Articles